The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Former Novartis subsidiary Alcon, after targeting the pharmaceutical eye drop scene with a trio of recent drug purchases, is adding another pair of arrows to its ophthalmic quiver. And this time, the ...
Narrow-moat Alcon discussed current projects and initiatives, pipeline progression, and long-term financial goals in its 2025 Capital Markets Day. After digesting the performance of each business unit ...
RxSight is going through a CEO transition at a critical time for the Aliso Viejo, CA-based op company. Aziz Mottiwala will take the helm July 20 as president and CEO, succeeding Ron Kurtz, MD. Kurtz ...
Alcon reported fourth-quarter sales growth of 8.6% and core diluted EPS growth of 4.5%, both shy of FactSet consensus estimates. Guidance for 2026 includes 6% and 10.5% growth in constant currency for ...
CHASKA, Minn., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore" or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”) ...
Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results